Sobi Selects Kinaxis to Accelerate Access to Life-Changing Treatments
By API User
AI-powered supply chain orchestration and rare-disease innovation join forces for faster delivery of critical therapies to patients in need OTTAWA, Ontario–BUSINESS WIRE– Kinaxis® (TSX:KXS), a global leader in end-to-end supply chain orchestration today announced that Swedish Orphan Biovitrum AB (Sobi), a leading international biopharmaceutical company, has elected to implement the Kinaxis Maestro® platform to facilitate … Continued